scispace - formally typeset
M

Mark E. Cooper

Researcher at University of Queensland

Publications -  1514
Citations -  141899

Mark E. Cooper is an academic researcher from University of Queensland. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 158, co-authored 1463 publications receiving 124887 citations. Previous affiliations of Mark E. Cooper include University of Cambridge & University of Adelaide.

Papers
More filters
Journal ArticleDOI

Multi-proxy reconstruction of surface water pCO2 in the northern Arabian Sea since 29ka

TL;DR: In this article, the results of a multi-proxy study to reconstruct surface water pCO2 concentrations in the northern Arabian Sea were reported, showing that this area of the oceans has been a constant source of CO2 to the atmosphere during the interval 5-29 ka, and that the intensity of this source was greatest between 11 and 17 ka, when atmospheric CO2 levels were rising rapidly.
Journal ArticleDOI

Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy

TL;DR: Long-term studies are needed to determine whether a decrease in albuminuria induced by CEI or CCB in patients with incipient diabetic nephropathy delays or reduces the subsequent rate of decline in glomerular filtration rate and renal structural changes.
Patent

Sulfonylureas and related compounds and use of same

TL;DR: In this article, a sulfonyl ureas and related compounds are used in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
Journal ArticleDOI

Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat

TL;DR: A role for CTR in the activation of some premigratory neuroblasts in the CNS is indicated as well as a possible role later in an undefined function associated with mature neurons of particular nuclei.
Journal ArticleDOI

Natural product libraries: assembly, maintenance, and screening.

TL;DR: This review discusses successful strategies and potential pitfalls to assembling a natural product-based library suitable for high-throughput screening and the logistics of moving from an assay hit to pure bioactive compound are discussed.